6:08 PM
 | 
Oct 26, 2012
 |  BC Extra  |  Company News

FDA denies Watson's formal dispute resolution request

Watson Pharmaceuticals Inc. (NYSE:WPI) said FDA denied the company's request for a formal dispute resolution related to a February complete response letter for Prochieve vaginal progesterone gel. The company was seeking approval...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >